VIA

Virtus Investment Advisers Portfolio holdings

AUM $349M
1-Year Est. Return 25.41%
This Quarter Est. Return
1 Year Est. Return
+25.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$296M
AUM Growth
-$72M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
512
New
Increased
Reduced
Closed

Top Buys

1
+$2.01M
2
+$1.82M
3
+$1.75M
4
CSCO icon
Cisco
CSCO
+$1.7M
5
STT icon
State Street
STT
+$1.69M

Top Sells

1
+$32.2M
2
+$24.6M
3
+$19M
4
SMC
Summit Midstream
SMC
+$3.67M
5
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$2.09M

Sector Composition

1 Financials 33.24%
2 Healthcare 17.43%
3 Technology 12.41%
4 Industrials 9.1%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAZE
401
Maze Therapeutics
MAZE
$1.57B
$85.2K 0.03%
+6,940
BHVN icon
402
Biohaven
BHVN
$1.1B
$85.1K 0.03%
6,032
+1,949
JANX icon
403
Janux Therapeutics
JANX
$1.76B
$85K 0.03%
3,679
+1,011
WVE icon
404
Wave Life Sciences
WVE
$1.18B
$84.9K 0.03%
13,060
+1,210
RVMD icon
405
Revolution Medicines
RVMD
$13.1B
$84.1K 0.03%
2,287
-1,365
CRNX icon
406
Crinetics Pharmaceuticals
CRNX
$4.05B
$84.1K 0.03%
2,923
-30
VRDN icon
407
Viridian Therapeutics
VRDN
$2.74B
$83.9K 0.03%
6,001
-3,128
MNMD icon
408
MindMed
MNMD
$1.1B
$83.6K 0.03%
12,881
-10,507
ANNX icon
409
Annexon
ANNX
$324M
$83.3K 0.03%
34,698
-1,701
TECX
410
Tectonic Therapeutic
TECX
$347M
$83.3K 0.03%
4,190
+649
RNA icon
411
Avidity Biosciences
RNA
$10.7B
$83.1K 0.03%
2,926
-1,934
SNDX icon
412
Syndax Pharmaceuticals
SNDX
$1.44B
$82.5K 0.03%
8,813
-3,379
IMTX icon
413
Immatics
IMTX
$1.24B
$82.4K 0.03%
15,315
-6,838
QURE icon
414
uniQure
QURE
$1.86B
$82K 0.03%
5,881
-5,025
TSHA icon
415
Taysha Gene Therapies
TSHA
$1.13B
$82K 0.03%
35,484
-37,473
RCUS icon
416
Arcus Biosciences
RCUS
$2.48B
$81.9K 0.03%
10,057
+485
KURA icon
417
Kura Oncology
KURA
$975M
$81.5K 0.03%
14,119
-2,823
KALV icon
418
KalVista Pharmaceuticals
KALV
$688M
$81.2K 0.03%
+7,184
ABUS icon
419
Arbutus Biopharma
ABUS
$869M
$81.2K 0.03%
26,266
-19,848
LQDA icon
420
Liquidia Corp
LQDA
$2.44B
$81.1K 0.03%
6,507
-8,403
NAMS icon
421
NewAmsterdam Pharma
NAMS
$4.35B
$81K 0.03%
4,471
-2,072
TRDA icon
422
Entrada Therapeutics
TRDA
$334M
$80.5K 0.03%
11,979
+2,914
EWTX icon
423
Edgewise Therapeutics
EWTX
$2.41B
$79.9K 0.03%
6,098
+269
SYRE icon
424
Spyre Therapeutics
SYRE
$1.82B
$79.5K 0.03%
5,310
-1,551
CGEM icon
425
Cullinan Oncology
CGEM
$505M
$79.1K 0.03%
10,506
-2,949
15 16
17
18 19